Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients
Clinical trial NCT04883138 · TERMINATED
Trial details
- NCT number
- NCT04883138
- Sponsor
- GigaGen, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-24
- Primary completion
- 2022-01-11
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.